From Rs 17.26 to Rs 48.50 per share in just 256 days: Heavy buying witnessed in this multibagger penny stock; Hit 52-week high today!
From Rs 17.26 to Rs 48.50 per share in just 256 days: Heavy buying witnessed in this multibagger penny stock; Hit 52-week high today!

From Rs 17.26 to Rs 48.50 per share in just 256 days: Heavy buying witnessed in this multibagger penny stock; Hit 52-week high today!

From Rs 17.26 to Rs 48.50 per share, the stock gave multibagger returns of 181 per cent in just 256 days.

Kiran Shroff Article rating: 5.0

From Rs 17.26 to Rs 48.50 per share, the stock gave multibagger returns of 181 per cent in just 256 days.

NIFTY Index Chart Analysis
NIFTY Index Chart Analysis

NIFTY Index Chart Analysis

CAUTION SHOULD BE THE WATCHWORD

Ninad Ramdasi Article rating: 5.0

L ast week, the domestic benchmark indices closed flat on a week-on-week basis but formed a bearish pattern (shooting star) that warrants attention.

Benchmark indices surge amidst mixed cues from European markets!
Benchmark indices surge amidst mixed cues from European markets!

Benchmark indices surge amidst mixed cues from European markets!

European markets are heading for a mixed open on Thursday, with sentiment tempered by declines stateside this week. European futures DAX, CAC and FTSE trade higher by 0.25 per cent, 0.36 per cent and 0.35 per cent respectively.

Siddharth Mane Article rating: 5.0

On April 16, 2024, foreign institutional investors (FII) offloaded shares worth Rs 4,468.09 crore, while domestic institutional investors (DII) bought shares worth Rs 2,040.38 crore.

Recommendation from Hotel, Resort & Restaurants and Railways Wagons
Recommendation from Hotel, Resort & Restaurants and Railways Wagons

Recommendation from Hotel, Resort & Restaurants and Railways Wagons

Ninad Ramdasi Article rating: 5.0

The scrips in this column have been recommended with a 15-day investment horizon in mind and carry high risk. Therefore, investors are advised to take into account their risk appetite before investing, as fundamentals may or may not back the recommendations.

9:5 bonus shares & stock split from Rs 10 to Rs 5 to Rs 1: Multibagger pharma distributor stock at Rs 116.55 was locked in the upper circuit on April 18
9:5 bonus shares & stock split from Rs 10 to Rs 5 to Rs 1: Multibagger pharma distributor stock at Rs 116.55 was locked in the upper circuit on April 18

9:5 bonus shares & stock split from Rs 10 to Rs 5 to Rs 1: Multibagger pharma distributor stock at Rs 116.55 was locked in the upper circuit on April 18

The stock gave multibagger returns of 185 per cent in just 1 year, 7,000 per cent in 3 years, and a whopping 21,400 per cent in 5 years.

Kiran Shroff Article rating: 4.0

The company's shares have an ROE of 71 per cent and an ROCE of 103 per cent

Analyse Your Portfolio At Pre-Retirement Stage
Analyse Your Portfolio At Pre-Retirement Stage

Analyse Your Portfolio At Pre-Retirement Stage

Hemant Rustagi Chief Executive Officer, Wiseinvest Pvt Ltd.

Ninad Ramdasi Article rating: 5.0

Mutual funds provide several options that allow you to generate tax-efficient regular income and make your money grow at a healthy rate. A systematic withdrawal plan (SWP) can be a smart strategy to achieve both these objectives.

Query Board
Query Board

Query Board

Ninad Ramdasi Article rating: 5.0

EID Parry (India) Ltd., a part of the Murugappa Group, manufactures sugar, nutraceuticals and ethanol.

Fund of Fortnight
Fund of Fortnight

Fund of Fortnight

Ninad Ramdasi Article rating: 5.0

Every fortnight, we recommend one open-ended equity diversified fund that has the best potential of returns for the next one year considering its constituents remain the same.

Recommendation from a Hotel, Resort & Restaurants
Recommendation from a Hotel, Resort & Restaurants

Recommendation from a Hotel, Resort & Restaurants

Ninad Ramdasi Article rating: 5.0

This section gives a recommendation of a stock having stock price below Rs 150 with sound fundamentals and expected to give handsome returns over a one-year time horizon.

India - A Cure For Pharma Outsourcing Woes?
India - A Cure For Pharma Outsourcing Woes?

India - A Cure For Pharma Outsourcing Woes?

CDMOs: Unsung Hero of Pharmaceutical Value Chain

Ninad Ramdasi Article rating: 5.0

The dynamic Indian market demands adaptability, with multinational companies outsourcing to comply with regulatory policies. Indian firms are also shifting towards asset-light models, focusing on core competencies.

DSIJ MINDSHARE

Mkt Commentary18-Apr, 2024

Penny Stocks18-Apr, 2024

Multibaggers18-Apr, 2024

Penny Stocks18-Apr, 2024

Multibaggers18-Apr, 2024

Knowledge

Technical18-Apr, 2024

General17-Apr, 2024

MF17-Apr, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR